1. Home
  2. FOLD vs INDB Comparison

FOLD vs INDB Comparison

Compare FOLD & INDB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FOLD
  • INDB
  • Stock Information
  • Founded
  • FOLD 2002
  • INDB 1907
  • Country
  • FOLD United States
  • INDB United States
  • Employees
  • FOLD N/A
  • INDB N/A
  • Industry
  • FOLD Biotechnology: Pharmaceutical Preparations
  • INDB Major Banks
  • Sector
  • FOLD Health Care
  • INDB Finance
  • Exchange
  • FOLD Nasdaq
  • INDB Nasdaq
  • Market Cap
  • FOLD 2.9B
  • INDB 2.8B
  • IPO Year
  • FOLD 2007
  • INDB N/A
  • Fundamental
  • Price
  • FOLD $6.16
  • INDB $61.01
  • Analyst Decision
  • FOLD Buy
  • INDB Buy
  • Analyst Count
  • FOLD 10
  • INDB 4
  • Target Price
  • FOLD $16.22
  • INDB $69.50
  • AVG Volume (30 Days)
  • FOLD 5.0M
  • INDB 282.5K
  • Earning Date
  • FOLD 05-01-2025
  • INDB 07-17-2025
  • Dividend Yield
  • FOLD N/A
  • INDB 3.86%
  • EPS Growth
  • FOLD N/A
  • INDB N/A
  • EPS
  • FOLD N/A
  • INDB 4.44
  • Revenue
  • FOLD $543,141,000.00
  • INDB $654,155,000.00
  • Revenue This Year
  • FOLD $19.85
  • INDB $27.60
  • Revenue Next Year
  • FOLD $23.50
  • INDB $25.32
  • P/E Ratio
  • FOLD N/A
  • INDB $13.75
  • Revenue Growth
  • FOLD 28.25
  • INDB N/A
  • 52 Week Low
  • FOLD $5.81
  • INDB $45.11
  • 52 Week High
  • FOLD $12.65
  • INDB $77.23
  • Technical
  • Relative Strength Index (RSI)
  • FOLD 41.91
  • INDB 44.96
  • Support Level
  • FOLD $6.03
  • INDB $59.78
  • Resistance Level
  • FOLD $6.37
  • INDB $63.40
  • Average True Range (ATR)
  • FOLD 0.24
  • INDB 1.72
  • MACD
  • FOLD 0.04
  • INDB -0.38
  • Stochastic Oscillator
  • FOLD 41.67
  • INDB 13.86

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a biotechnology company focused on discovering, developing and delivering medicines for people living with rare metabolic diseases. The company is engaged in developing a pipeline of medicines for rare metabolic diseases, including a rare disease gene therapy portfolio. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of advanced therapies to treat a range of devastating rare and orphan diseases.

About INDB Independent Bank Corp.

Independent Bank Corp is a bank holding company and the sole shareholder of its bank, the Rockland Trust Company. Rockland is a community-oriented commercial bank. The bank provides a variety of banking, investment and financial services, operating with various retail branches, as well as a network of commercial and residential lending centers and investment management offices majorly in Eastern Massachusetts, Worcester County, and Rhode Island. The bank's loan portfolio constitutes the bulk of the bank's total assets. Its borrowers consist mostly of small to medium-size businesses and consumers, majority of which are made to its market area in eastern Massachusetts and Rhode Island. The bank's loan portfolio is predominantly in commercial loans.

Share on Social Networks: